Design Therapeutics

Design Therapeutics is a biotechnology company dedicated to developing novel therapies for severe degenerative diseases caused by nucleotide repeat expansions. The company's lead program focuses on treating Friedreich's ataxia, with additional drug discovery efforts underway for other degenerative diseases.